---
schema_version: '1.0'
id: news-20260821-9138bf
title: 中国の人気だが不透明な臨床試験で3人目の死亡が判明、今回はCAR-T療法で
url: https://bio.nikkeibp.co.jp/atcl/column/16/112800083/082000109/
url_hash: 9138bfaf77c7a875095cb969e0f4db0adc1f68e61fbb8768d93287d2c4fe5d16
canonical_url: https://bio.nikkeibp.co.jp/atcl/column/16/112800083/082000109
source: bio.nikkeibp.co.jp
category: news/health
category_raw: health
region: null
tags:
- health
- clinical_trial
- gene_therapy
- car_t
- death_in_trial
lang: null
published_at: null
fetched_at: '2026-08-21T05:46:09.765442Z'
updated_at: '2026-08-21T05:46:11Z'
status: published
content_hash: null
content_changed_at: null
license_note: link-only
summary: null
summary_source: null
summary_en: null
summary_omitted_reason: license_restricted
redistribution: false
keywords_en:
- CAR-T
- car_t
- clinical_trial
- death_in_trial
- gene_therapy
- health
- Health ISAC Japan
- news
entities_en:
- name: Health ISAC Japan
  type: organization
topics_en:
- news
numeric_facts: []
entities:
- name: Health ISAC Japan
  type: organization
key_facts: []
related: []
related_auto:
- name: パーソルクロステクノロジー株式会社
  type: organization
  weight: 1.0
computed_at: '2026-08-21T05:46:11Z'
---

# 中国の人気だが不透明な臨床試験で3人目の死亡が判明、今回はCAR-T療法で

## TL;DR
（要約なし・原文はリンク先を参照 / No summary available; see the source link.）

## Key Points
- health / clinical_trial / gene_therapy / car_t / death_in_trial

## Details
(本文なし。リンク先参照)

## Source
元記事: [中国の人気だが不透明な臨床試験で3人目の死亡が判明、今回はCAR-T療法で](https://bio.nikkeibp.co.jp/atcl/column/16/112800083/082000109/)